John Caroll and Eamonn Colley

Detecting Disease with Vexev

Date Published:
October 22, 2020

John Carroll & Eamonn Colley from Vexev talk about how they plan to stop vascular disease in its tracks.

Vascular disease is the leading cause of death worldwide, and heart attacks are sudden and strike with no notice. What if you could know when you were about to have a heart attack? Currently symptoms do not appear until the late stages, often when it is too late. Two PhD students, John Carroll and Eamonn Colley, made a breakthrough discovery that enables a radically earlier diagnosis.

Their company, Vexev is on a mission to transcend humanity beyond vascular disease. In this episode, we will look at how the founders went from academics to entrepreneurs and why Tip Piumsomboon was so convinced by their idea.

Listen and subscribe to the Wild Hearts podcast.